Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - ketamine hydrochloride, quantity: 57.67 mg/ml (equivalent: ketamine, qty 50 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - ketamine interpharma? is recommended:,1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine interpharma ? is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - ketamine hydrochloride, quantity: 57.67 mg/ml (equivalent: ketamine, qty 50 mg/ml) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ketamine interpharma? is recommended:,1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. ketamine interpharma ? is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents; 3. to supplement low-potency agents, such as nitrous oxide.

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketamine hydrochloride injection is indicated: - as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. - for the induction of anesthesia prior to the administration of other general anesthetic agents. - as a supplement to other anesthetic agents. - ketamine hydrochloride injection is contraindicated in patients for whom a significant elevation of blood pressure would constitute a serious hazard [see warnings and precautions (5.1)] . - ketamine hydrochloride injection is contraindicated in patients with known hypersensitivity to ketamine or to any excipient [see adverse reactions (6)] . risk summary there are no adequate and well-controlled studies of ketamine hydrochloride injection in pregnant women. in animal reproduction studies in rats developmental delays (hypoplasia of skeletal tissues) were noted at 0.3 times the human intramuscular dose of 10 mg/kg. in rabbits, developmental delays and increased fetal resorptions were noted at 0.6 times the

Ireland - English - HPRA (Health Products Regulatory Authority)

eurovet animal health b.v. - ketamine hydrochloride - solution for injection - 100 milligram(s)/millilitre - ketamine - cats, dogs, horses - neurological preparations

United States - English - NLM (National Library of Medicine)

dechra veterinary products - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketamine hydrochloride injection may be used in cats for restraint or as the sole anesthetic agent for diagnostic or minor, brief, surgical procedures that do not require skeletal muscle relaxation. it may be used in subhuman primates for restraint. ketamine hydrochloride injection is contraindicated in cats and subhuman primates suffering from renal or hepatic insufficiency. ketamine hydrochloride injection is detoxified by the liver and excreted by the kidneys; therefore, any preexistent hepatic or renal pathology or impairment of function can be expected to result in prolonged anesthesia; related fatalities have been reported.

Australia - English - Department of Health (Therapeutic Goods Administration)

biomed aust pty ltd - ketamine hydrochloride, quantity: 115.3 mg (equivalent: ketamine, qty 100 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. biomed ketamine is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents. 3. to supplement low-potency agents, such as nitrous oxide.

United States - English - NLM (National Library of Medicine)

covetrus north america - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketamine hydrochloride injection may be used in cats for restraint or as the sole anesthetic agent for diagnostic or minor, brief, surgical procedures that do not require skeletal muscle relaxation. it may be used in subhuman primates for restraint. ketamine hydrochloride injection is contraindicated in cats and subhuman primates suffering from renal or hepatic insufficiency. ketamine hydrochloride injection is detoxified by the liver and excreted by the kidneys; therefore, any preexistent hepatic or renal pathology or impairment of function can be expected to result in prolonged anesthesia; related fatalities have been reported.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - ketamine hydrochloride 57.5 mg/ml equivalent to 50 mg/ml ketamine - solution for injection - 50 mg/ml - active: ketamine hydrochloride 57.5 mg/ml equivalent to 50 mg/ml ketamine excipient: benzethonium chloride water for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - ketamine hydrochloride -

United States - English - NLM (National Library of Medicine)

mwi/vetone - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketamine 100 mg in 1 ml - zetamine™ may be used in cats for restraint or as the sole anesthetic agent for diagnostic or minor, brief, surgical procedures that do not require skeletal muscle relaxation. it may be used in subhuman primates for restraint. zetamine™ is contraindicated in cats and subhuman primates suffering from renal or hepatic insufficiency. zetamine™ is detoxified by the liver and excreted by the kidneys; therefore, any preexistent hepatic or renal pathology or impairment of function can be expected to result in prolonged anesthesia; related fatalities have been reported.